[1]何涛,索志超,孔德强,等.术前血清CTRP3,CTRP9水平与缺血性脑卒中患者颈动脉支架成形术后再狭窄的相关性研究[J].卒中与神经疾病杂志,2022,29(05):427-431.[doi:10.3969/j.issn.1007-0478.2022.05.006]
　e Tao*,Suo Zhichao,Kong Deqiang*,et al.Correlation between preoperative serum CTRP3, CTRP9 levels and restenosis after carotid artery stenting in patients with cerebral ischemic stroke[J].Stroke and Nervous Diseases,2022,29(05):427-431.[doi:10.3969/j.issn.1007-0478.2022.05.006]
点击复制

术前血清CTRP3,CTRP9水平与缺血性脑卒中患者颈动脉支架成形术后再狭窄的相关性研究()
分享到：

《卒中与神经疾病》杂志[ISSN:1007-0478/CN:42-1402/R]

卷:
第29卷
期数:
2022年05期
页码:
427-431
栏目:
论著
出版日期:
2022-10-10

文章信息/Info

Title:
Correlation between preoperative serum CTRP3, CTRP9 levels and restenosis after carotid artery stenting in patients with cerebral ischemic stroke
文章编号:
1007-0478(2022)05-0427-05
作者:
何涛; 索志超; 孔德强; 吕爱娣
065000 河北省廊坊市人民医院神经内科（何涛 孔德强 吕爱娣），检验科［索志超（通信作者）］
Author(s):
e Tao*;  Suo Zhichao;  Kong Deqiang*;  et al.
Department of Neurology, Langfang People's Hospital, Langfang Hebei 065000
关键词:
补体C1q/肿瘤坏死因子相关蛋白3; 补体C1q/肿瘤坏死因子相关蛋白9; 缺血性脑卒中; 颈动脉支架成形术; 支架内再狭窄
Keywords:
Complement-C1q TNF-related protein 3; Complement-C1q TNF-related protein 9; Cerebral ischemic stroke; Carotid artery stenting; In-stent restenosis
分类号:
R743.3
DOI:
10.3969/j.issn.1007-0478.2022.05.006
文献标志码:
A
摘要:
目的 探讨血清补体C1q/肿瘤坏死因子相关蛋白3（Complement-C1q TNF-related protein 3，CTRP3）、补体C1q/肿瘤坏死因子相关蛋白9（Complement-C1q TNF-related protein 9，CTRP9）水平与缺血性脑卒中（Cerebral ischemic stroke，CIS）患者颈动脉支架成形术（Carotid artery stenting，CAS）后支架内再狭窄（In-stent restenosis，ISR）的关系。 方法 选取2018年2月-2021年2月在廊坊市人民医院诊治的234例CIS患者为CIS组，其中CAS后1年内出现ISR的患者作为ISR组（42例），未出现ISR的患者作为NISR组（192例）；另选择同期体检健康者85例为对照组；检测CIS患者入院后CAS术前、体检健康者体检时血清CTRP3、CTRP9水平；收集CIS患者的临床资料；分析CIS患者血清CTRP3，CTRP9水平与临床指标的相关性、CAS后发生ISR的影响因素，血清CTRP3，CTRP9水平对CIS患者CAS后发生ISR的预测价值。 结果 与对照组比较，CIS组血清CTRP3，CTRP9水平降低（P＜0.05）；与NISR组比较，ISR组血清CTRP3，CTRP9水平降低，术前超敏C反应蛋白（High sensitivity C-reactive protein，hs-CRP）、术前白细胞计数、术前中性粒细胞计数、支架数量、残留狭窄程度比例升高（P＜0.05）；CIS患者血清CTRP3，CTRP9水平与术前hs-CRP水平、术前白细胞计数、术前中性粒细胞计数、支架数量、残留狭窄程度均呈负相关（r<-0.318，P＜0.05）；支架数量多、血清CTRP3低水平、CTRP9低水平为CIS患者CAS后发生ISR的危险因素（P＜0.05）；血清CTRP3，CTRP9、二者联合预测CIS患者CAS后发生ISR的曲线下面积分别为0.811、0.798、0.934，二者联合的预测价值显著高于单一指标（P＜0.05）。 结论 术前血清CTRP3，CTRP9水平异常降低与CIS患者CAS后发生ISR有关，可作为CIS患者CAS后预后评估的生物学指标。
Abstract:
Objective To investigate the relationship between serum Complement-C1q TNF-related protein 3 (CTRP3), Complement-C1q TNF-related protein 9 (CTRP9) levels and in-stent restenosis (ISR) after carotid artery stenting (CAS) in cerebral ischemic stroke (CIS) patients. Methods 234 patients with CIS treated in Langfang people's Hospital from February 2018 to February 2021 were selected as CIS group, of which patients with ISR within 1 year after CAS were selected as ISR group (42 cases) and patients without ISR were selected as NISR group (192 cases). In addition, 85 healthy persons in the same period were selected as the control group. The levels of serum CTRP3, CTRP9 were measured in patients with CIS before CAS and in healthy subjects during physical examination; collect the clinical data of CIS patients; analyze the correlation between the levels of serum CTRP3, CTRP9 in patients with CIS and clinical indicators, influencing factors of ISR after CAS, and predictive value of serum CTRP3 and CTRP9 levels for ISR after CAS in patients with CIS. Results Compared with the control group, the levels of serum CTRP3 and CTRP9 in CIS group decreased (P<0.05); compared with NISR group, the levels of serum CTRP3 and CTRP9 in ISR group decreased, and the proportion of preoperative high sensitivity-C reactive protein (hs-CRP), preoperative leukocyte count, preoperative neutrophil count, number of supports and proportion of residual stenosis increased (P<0.05); the levels of serum CTRP3 and CTRP9 in patients with CIS were negatively correlated with preoperative hs-CRP, preoperative leukocyte count, preoperative neutrophil count, number of supports and degree of residual stenosis (P<0.05); the large number of supports, the low level of serum CTRP3 and CTRP9 were the risk factors of ISR after CAS in patients with CIS (P<0.05); the areas under curve of serum CTRP3, CTRP9 and their combination in predicting ISR after CAS in patients with CIS were 0.811, 0.798 and 0.934 respectively, the predictive value of their combination was significantly higher than that of a single index (P<0.05). Conclusion The abnormal decrease of preoperative serum CTRP3 and CTRP9 levels is related to ISR after CAS in patients with CIS, which can be used as a biological index for the evaluation of prognosis after CAS in patients with CIS.

参考文献/References:

[1] 吴佐军,董金凤,杨杨,等.2002—2019年天津市蓟州区缺血性脑卒中死亡率趋势分析[J].中国慢性病预防与控制,2021,29(6):470-473.
[2] Keskin M, cal L, Cer �瘙 塂 it S, et al. The predictive role of a novel risk index in patients undergoing carotid artery stenting: systemic Immune-Inflammation index[J]. J Stroke Cerebrovasc Dis, 2021, 30(9): 105955.
[3] Haidegger M, Kneihsl M, Niederkorn K, et al. Mean platelet volume does not predict restenosis after carotid artery stenting in whites[J]. Stroke, 2020, 51(3): 986-989.
[4] Maida CD, Norrito RL, Daidone M, et al. Neuroinflammatory mechanisms in ischemic stroke: focus on cardioembolic stroke, background, and therapeutic approaches[J]. Int J Mol Sci, 2020, 21(18): 6454.
[5] Malekmohammad K, Bezsonov EE, Rafieian-Kopaei M. Role of lipid accumulation and inflammation in atherosclerosis: focus on molecular and cellular mechanisms[J]. Front Cardiovasc Med, 2021, 8(1): 707529.
[6] Guo B, Zhuang T, Xu F, et al. New insights into implications of CTRP3 in obesity, metabolic dysfunction, and cardiovascular diseases: potential of therapeutic interventions[J]. Front Physiol, 2020, 11(1): 570270.
[7] Lin JM, Hsu CH, Chen JC, et al. BCL-6 promotes the methylation of miR-34a by recruiting EZH2 and upregulating CTRP9 to protect ischemic myocardial injury[J]. Biofactors, 2021, 47(3): 386-402.
[8] 高峰,杜彬,秦海强,等.2007年颈动脉支架成形术专家共识[J].中国卒中杂志,2007,2(5):430-454.
[9] 中华医学会神经病学分会.中华医学会神经病学分会脑血管病学组.中国急性缺血性脑卒中诊治指南2018[J].中华神经科杂志,2018,51(9):666-682.
[10]Fathy N, Kortam MA, Shaker OG, et al. Long noncoding RNAs MALAT1 and ANRIL gene variants and the risk of cerebral ischemic stroke: an association study[J]. ACS Chem Neurosci, 2021, 12(8): 1351-1362.
[11]张继冲,宋云.颈动脉支架内再狭窄[J].国际脑血管病杂志,2021,29(4):294-297.
[12]Zhang J, Lin X, Xu J, et al. CTRP3 protects against uric acid-induced endothelial injury by inhibiting inflammation and oxidase stress in rats[J]. Exp Biol Med (Maywood), 2022, 247(2): 174-183.
[13]Wan Y, Wang J, Yang B, et al. Effects and mechanisms of CTRP3 overexpression in secondary brain injury following intracerebral hemorrhage in rats[J]. Exp Ther Med, 2022, 23(1): 35.
[14]Chen L, Qin L, Liu X, et al. CTRP3 alleviates Ox-LDL-Induced inflammatory response and endothelial dysfunction in mouse aortic endothelial cells by activating the PI3K/Akt/eNOS pathway[J]. Inflammation, 2019, 42(4): 1350-1359.
[15]贾梦奇,邢帅帅,赵根尚,等.血清CTRP3、CXCR4水平与冠心病行PCI后患者支架内再狭窄的关系[J].中国循证心血管医学杂志,2021,13(8):969-972.
[16]Niemann B, Li L. Siegler D[J]. CTRP9 Mediates Protective Effects in Cardiomyocytes via AMPK-and Adiponectin Receptor-Mediated Induction of Anti-Oxidant Response[J].Cells, 2020, 9(5): 1229-1237.
[17]Huang C, Zhang P, Li T, et al. Overexpression of CTRP9 attenuates the development of atherosclerosis in apolipoprotein E-deficient mice[J]. Mol Cell Biochem, 2019, 455(1/2): 99-108.
[18]Gao C, Zhao SS, Lian K, et al. C1q/TNF-related protein 3 (CTRP3) and 9 (CTRP9) concentrations are decreased in patients with heart failure and are associated with increased morbidity and mortality[J]. BMC Cardiovasc Disord, 2019, 19(1): 139.
[19]张翔,陈薪旭,冯晓丽.急性脑梗死患者血清CTRP3,CTRP9水平与颈总动脉内膜中层厚度的相关性分析[J].卒中与神经疾病,2021,28(2):162-166.
[20]Pan J, Cui X, Wang G, et al. Predictive value of serum CTRP9 and STIM1 for restenosis after cerebrovascular stent implantation and its relationship with vasoactive substances and inflammatory cytokines[J]. Exp Ther Med, 2020, 20(3): 2617-2622.

备注/Memo

备注/Memo:
基金项目：河北省医学科学研究课题计划项目（编号20201306）；廊坊市科技支撑计划项目（编号为2020013074）
更新日期/Last Update: 2022-10-10